rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2003-5-5
|
pubmed:abstractText |
DISC-hGMCSF is a gH-deleted HSV-2 based vector expressing human GM-CSF that has entered clinical trials for the therapy of metastatic melanoma. To determine whether this product also has potential to treat breast carcinoma, a series of in vitro and in vivo studies were made.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1099-498X
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2003 John Wiley & Sons, Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
407-16
|
pubmed:dateRevised |
2006-4-21
|
pubmed:meshHeading |
pubmed-meshheading:12731089-Animals,
pubmed-meshheading:12731089-Antimetabolites, Antineoplastic,
pubmed-meshheading:12731089-Breast Neoplasms,
pubmed-meshheading:12731089-Cell Line, Tumor,
pubmed-meshheading:12731089-Cell Separation,
pubmed-meshheading:12731089-Centrifugation,
pubmed-meshheading:12731089-Female,
pubmed-meshheading:12731089-Flow Cytometry,
pubmed-meshheading:12731089-Fluorouracil,
pubmed-meshheading:12731089-Gene Therapy,
pubmed-meshheading:12731089-Genetic Vectors,
pubmed-meshheading:12731089-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:12731089-Green Fluorescent Proteins,
pubmed-meshheading:12731089-Herpesvirus 2, Human,
pubmed-meshheading:12731089-Humans,
pubmed-meshheading:12731089-Luminescent Proteins,
pubmed-meshheading:12731089-Mammary Neoplasms, Animal,
pubmed-meshheading:12731089-Mice,
pubmed-meshheading:12731089-Mice, Inbred BALB C,
pubmed-meshheading:12731089-Phenotype,
pubmed-meshheading:12731089-Time Factors
|
pubmed:year |
2003
|
pubmed:articleTitle |
Preclinical evaluation of DISC-GMCSF for the treatment of breast carcinoma.
|
pubmed:affiliation |
Xenova Group plc, 310 Cambridge Science Park, UK. Peter_Loudon@xenova.co.uk
|
pubmed:publicationType |
Journal Article
|